Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst. (May 2021)

• Record Type: Journal Article
• Authors: Shallis, Rory M.; Weiss, Julian J.; Deziel, Nicole C.; Gore, Steven D.
• Is Part Of: Blood reviews. Volume 47(2021)
• Publication Date: 2021-05
• Subjects: Acute myeloid -- AML -- Leukemia -- Leukemogenesis -- Leukemogens -- Secondary -- Toxins; Hematology -- Periodicals; Hematology -- Periodicals; Hématologie -- Périodiques; Hematology; Electronic journals; Periodicals; 616.15
• DOI: 10.1016/j.blre.2020.100760
• Languages: English
• ISSNs: 0268-960X

Abstract

Abstract: Myeloid neoplasms like acute myeloid leukemia (AML) originate from genomic disruption, usually in a multi-step fashion. Hematopoietic stem/progenitor cell acquisition of abnormalities in vital cellular processes, when coupled with intrinsic factors such as germline predisposition or extrinsic factors such as the marrow microenvironment or environmental agents, can lead to requisite pre-leukemic clonal selection, expansion and evolution. Several of these entities have been invoked as "leukemogens." The known leukemogens are numerous and are found in the therapeutic, occupational and ambient environments, however they are often difficult to implicate for individual patients. Patients treated with particular chemotherapeutic agents or radiotherapy accept a calculated risk of therapy-related AML. Occupational exposures to benzene, dioxins, formaldehyde, electromagnetic and particle radiation have been associated with an increased risk of AML. Although regulatory agencies have established acceptable exposure limits in the workplace, accidental exposures and even ambient exposures to leukemogens are possible. It is plausible that inescapable exposure to non-anthropogenic ambient leukemogens may be responsible for many cases of non-inherited de novo AML. In this review, we discuss the current understanding of leukemogens as they relate to AML, assess to what extent the term " de novo " leukemia is meaningful, and describe the potential to identify and characterize new leukemogens.